MREM Press Releases
- February 14, 2019
Talk To A Malaysian Doctor While Travelling Abroad – DoctorOnCall collaborates with Tune Protect to launch AirAsia Tune Protect Travel Protection Policy
KUALA LUMPUR, Malaysia, Feb 14 (Bernama-PRNewswire) — In 2016, it was estimated that there were 11.9 million international travels made by Malaysians and it is anticipated to increase to 14.2 million in 2021. Travelling has been one of the popular activities enjoyed by Malaysians especially the younger generation. Part of this
- February 13, 2019
YITU Healthcare Publishes Major AI Breakthrough In Diagnostic Accuracy On Nature Medicine As Co-First Author
SHANGHAI, Feb 13 (Bernama-BUSINESS WIRE) — YITU Healthcare has successfully used natural language processing (NLP) to achieve high accuracy rates on par with doctors when reading electronic health records and generating patient diagnoses. The result is published on Nature Medicineunder “Evaluation and Accurate Diagnoses of Pediatric Diseases using Artificial Intelligence”. It’s the
- February 13, 2019
Digital Reasoning Announces Strategic Investment from Macquarie Group in new Partnership
NASHVILLE, Tenn., Feb 13 (Bernama-GLOBE NEWSWIRE) —Digital Reasoning, a leader in Artificial Intelligence (AI) for Language Process Automation (LPA) and Human Behavioral Insights (HBI), today announced a strategic investment from Macquarie Group. Digital Reasoning will also partner with Macquarie to explore innovative new financial services use cases for its award-winning
- February 13, 2019
Privitar Launches A New Office In Singapore To Further Its Global Footprint
SINGAPORE, Feb 13 (Bernama-BUSINESS WIRE) — Privacy engineering firm Privitar today announced the opening of its Singapore office to support the APAC region. Over the last year, the company has rapidly expanded in response to the growing demand for software products employing leading privacy enhancing techniques. Privitar is leading the development
- February 12, 2019
Jumio Launches First End-To-End Biometric Verification Solution Coupling Identity Proofing with Ongoing 3D Face Authentication
LONDON, Feb 12 (Bernama-GLOBE NEWSWIRE) — Jumio, the leading AI-powered trusted identity as a service provider, today announces the launch of Jumio Authentication. This new video-selfie authentication solution is the first in the market to leverage biometrics for initial identity proofing and ongoing user authentication — creating an online experience that is fast,
- February 12, 2019
CFM Animation Challenge to educate Malaysian Consumers
CYBERJAYA, Feb 12 (Bernama) — Animation not only features entertaining characters and movements but has become one of the most important medium of today’s world to attract audiences and facilitate message delivery. Realizing that, the Communications and Multimedia Consumer Forum of Malaysia (CFM) is providing an opportunity to challenge budding and
- February 12, 2019
Malindo Air Now Offers You More Bite On-Board
PETALING JAYA, Feb 12 (Bernama) — Malindo Air has ushered into the New Year by modifying their in-flight services to better accommodate the needs of their passengers. A wider range of snacks and beverages are now available for purchase onboard its Boeing fleet. These include hot beverages such as coffee and
- February 12, 2019
Launch of IIFL India Equity Opportunities Fund (UCITS Fund Based in Luxembourg)
MUMBAI, India, Feb 12 (Bernama-BUSINESS WIRE) — IIFL Asset Management (IIFL AMC) is pleased to announce the launch of its first Luxembourg domiciled UCITS Fund, IIFL India Equity Opportunities Fund (‘IIFL Fund’) by virtue of merger of Ashburton India Equity Opportunities Fund into IIFL Fund. Pursuant to this, IIFL Fund has commenced
- February 11, 2019
Samsung Bioepis And C-Bridge Capital To Develop And Commercialize Next-Generation Biosimilars In China
INCHEON, Korea, Feb 11 (Bernama-BUSINESS WIRE) — Samsung Bioepis Co., Ltd. today announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung Bioepis, including third-wave biosimilar candidates SB11 and SB12, which reference LUCENTIS® (ranibizumab) and SOLIRIS® (eculizumab), respectively, as well as SB3,
- February 11, 2019
Harry Potter: Hogwarts Mystery Brings New Choices, Challenges and Couture with February Sidequest, the Celestial Ball
LOS ANGELES, Feb 11 (Bernama-BUSINESS WIRE) — Jam City: Who:Jam City, a Los Angeles-based mobile games studio, in partnership with Warner Bros. Interactive Entertainment’s Portkey Games, a label dedicated to creating new Wizarding World mobile and videogame experiences that place the player at the center of their own adventure, inspired